Wockhardt Performance
- Today's Low
- ₹1,792
- Today's High
- ₹1,878
- 52 Week Low
- ₹1,087
- 52 Week High
- ₹2,422
- Open Price₹1,805
- Previous Close₹1,811
- Volume717,477
- 50 DMA₹1,800.19
- 100 DMA₹1,665.18
- 200 DMA₹1,549.06
Wockhardt Chart
Investment Returns
- Over 1 Month -4.31%
- Over 3 Month + 36.04%
- Over 6 Month + 33.65%
- Over 1 Year + 5.54%
Smart Investing Starts Here Start SIP with Wockhardt for Steady Growth!
Wockhardt Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 141.5
- PEG Ratio
- 0.3
- Market Cap Cr
- 30,134
- P/B Ratio
- 6.1
- Average True Range
- 81.35
- EPS
- 17.48
- Dividend Yield
- 0
- MACD Signal
- 29.38
- RSI
- 47.08
- MFI
- 32.33
Latest Stock News Updates
Wockhardt's FDA-approved Zaynich marks a breakthrough in India's pharmaceutical innovation, offering a new weapon against antimicrobial resistance
- Business Standard
- 1 week ago
Wockhardt expects novel drugs to contribute over half its revenue within five years as it expands a differentiated antibiotic portfolio built through decades of RD
- Business Standard
- 1 month ago
Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for urinary tract infections. The company also reported a strong turnaround in its March quarter results. Revenue and profit saw significant year-on-year growth. Biotech operations were a key driver of this improved performance.
- Economic Times
- 1 month 1 week ago
Wockhardt Financials
Wockhardt Technicals
EMA & SMA
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹1,892.40
- 50 Day
- ₹1,800.20
- 100 Day
- ₹1,665.20
- 200 Day
- ₹1,549.10
Resistance and Support
- R3 1,976.30
- R2 1,927.10
- R1 1,890.80
- S1 1,805.30
- S2 1,756.10
- S3 1,719.80
Wockhardt Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-04 | Audited Results & Others | Inter-alia, to consider 1. Raising of funds by issue of Equity Shares, American Depository Receipts , Foreign Currency Convertible Bonds or any combination thereof or any other method. issue of equity shares of Rs. 5/- each in the ratio of 3:10 @ premium of Rs. 220/-. |
| 2026-02-10 | Quarterly Results | |
| 2025-11-03 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-29 | Audited Results & Fund Raising |
About Wockhardt
- NSE Symbol
- WOCKPHARMA
- BSE Symbol
- 532300
- Managing Director
- Dr. Murtaza Khorakiwala
- ISIN
- INE049B01025
Similar Stocks to Wockhardt
Popular Stocks
Wockhardt FAQs
Wockhardt share price is ₹1,854 As on 14 July, 2026 | 07:34
The Market Cap of Wockhardt is ₹30134.2 Cr As on 14 July, 2026 | 07:34
The P/E ratio of Wockhardt is 141.5 As on 14 July, 2026 | 07:34
The PB ratio of Wockhardt is 6.1 As on 14 July, 2026 | 07:34
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.